Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

30-01-2021 | Original Paper

Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III

Auteurs: Anjali Sadhwani, Anne Wheeler, Angela Gwaltney, Sarika U. Peters, Rene L. Barbieri-Welge, Lucia T. Horowitz, Lisa M. Noll, Rachel J. Hundley, Lynne M. Bird, Wen-Hann Tan

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 2/2023

Abstract

We describe the development of 236 children with Angelman syndrome (AS) using the Bayley Scales of Infant and Toddler Development, Third Edition. Multilevel linear mixed modeling approaches were used to explore differences between molecular subtypes and over time. Individuals with AS continue to make slow gains in development through at least age 12 years of age at about 1–2 months/year based on age equivalent score and 1–16 growth score points/year depending on molecular subtype and domain. Children with a deletion have lower scores at baseline and slower rate of gaining skills while children with UBE3A variant subtype demonstrated higher scores as well as greater rates of skill attainment in all domains. The developmental profiles of UPD and ImpD were similar.

vorige artikel Structural and Pragmatic Language Impairments in Children Evaluated for Autism Spectrum Disorder (ASD)

volgende artikel Pilot Survey: Police Understanding of Autism Spectrum Disorder

Andersen, W. H., Rasmussen, R. K., & Strømme, P. (2001). Levels of cognitive and linguistic development in Angelman syndrome: A study of 20 children. Logopedics Phoniatrics Vocology, 26(1), 2–9. https://doi.org/10.1080/14015430117324.CrossRefPubMed

Bayley, N. (2006). Bayley scales of infant and toddler development: PsychCorp, Pearson. San Antonio, TX: Harcourt Assessment Inc..

Bindels-de Heus, K., Mous, S. E., Ten Hooven-Radstaake, M., van Iperen-Kolk, B. M., Navis, C., Rietman, A. B., et al. (2020). An overview of health issues and development in a large clinical cohort of children with Angelman syndrome. American Journal of Medical Genetics. Part A, 182(1), 53–63. https://doi.org/10.1002/ajmg.a.61382.CrossRefPubMed

Bird, L. M. (2014). Angelman syndrome: Review of clinical and molecular aspects. The Application of Clinical Genetics, 7, 93–104. https://doi.org/10.2147/TACG.S57386.CrossRefPubMedPubMedCentral

Bode, M. M., D'Eugenio, D. B., Mettelman, B. B., & Gross, S. J. (2014). Predictive validity of the Bayley, at 2 years for intelligence quotient at 4 years in preterm infants. Journal of Developmental & Behavioral Pediatrics, 35(9), 570–575. https://doi.org/10.1097/DBP.0000000000000110.CrossRef

Brun Gasca, C., Obiols, J., Bonillo, A., Artigas, J., Lorente, I., Gabau, E., . . . Turk, J. (2010). Adaptive behaviour in Angelman syndrome: Its profile and relationship to age. Journal of Intellectual Disability Research, 54(11), 1024–1029. doi: https://doi.org/10.1111/j.1365-2788.2010.01331.x.CrossRefPubMed

Buntinx, I. M., Hennekam, R. C., Brouwer, O. F., Stroink, H., Beuten, J., Mangelschots, K., & Fryns, J.-P. (1995). Clinical profile of Angelman syndrome at different ages. American Journal of Medical Genetics, 56(2), 176–183. https://doi.org/10.1002/ajmg.1320560213.CrossRefPubMed

Clayton-Smith, J., & Laan, L. (2003). Angelman syndrome: A review of the clinical and genetic aspects. Journal of Medical Genetics, 40(2), 87–95. https://doi.org/10.1136/jmg.40.2.87.CrossRefPubMedPubMedCentral

Dagli, A., Buiting, K., & Williams, C. A. (2012). Molecular and clinical aspects of Angelman syndrome. Molecular Syndromology, 2(3–5), 100–112 doi: 000328837.PubMed

Di Nuovo, S., & Buono, S. (2011). Behavioral phenotypes of genetic syndromes with intellectual disability: Comparison of adaptive profiles. Psychiatry Research, 189(3), 440–445. https://doi.org/10.1016/j.psychres.2011.03.015.CrossRefPubMed

Farmer, C., Kaat, A., Thurm, A., Anselm, I., Akshoomoff, N., Bennett, A., Berry, L., Bruchey, A., Barshop, B., Berry-Kravis, E., Bianconi, S., Cecil, K., Davis, R., Ficicioglu, C., Porter, F., Wainer, A., Goin-Kochel, R., Leonczyk, C., Guthrie, W., et al. (2020). Person ability scores as an alternative to norm-referenced scores as outcome measures in studies of neurodevelopmental disorders. American Journal on Intellectual and Developmental Disabilities, 125(6), 475–480. https://doi.org/10.1352/1944-7558-125.6.475.CrossRefPubMed

Gentile, J. K., Tan, W.-H., Horowitz, L. T., Bacino, C. A., Skinner, S. A., Barbieri-Welge, R., et al. (2010). A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. Journal of Developmental and Behavioral Pediatrics: JDBP, 31(7), 592. https://doi.org/10.1097/DBP.0b013e3181ee408e.CrossRefPubMed

Grieco, J. C., Ciarlone, S. L., Gieron-Korthals, M., Schoenberg, M. R., Smith, A. G., Philpot, R. M., et al. (2014). An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome. BMC Neurology, 14, 232. https://doi.org/10.1186/s12883-014-0232-x.CrossRefPubMedPubMedCentral

Guerrini, R., Carrozzo, R., Rinaldi, R., & Bonanni, P. (2003). Angelman syndrome. Pediatric Drugs, 5(10), 647–661. https://doi.org/10.2165/00148581-200305100-00001.CrossRefPubMed

Lalande, M., & Calciano, M. (2007). Molecular epigenetics of Angelman syndrome. Cellular and Molecular Life Sciences, 64(7–8), 947. https://doi.org/10.1007/s00018-007-6460-0.CrossRefPubMed

Lichtenberger, E. O. (2005). General measures of cognition for the preschool child. Mental Retardation and Developmental Disabilities Research Reviews, 11(3), 197–120.CrossRefPubMed

Lossie, A. C., Whitney, M. M., Amidon, D., Dong, H. J., Chen, P., Theriaque, D., et al. (2001). Distinct phenotypes distinguish the molecular classes of Angelman syndrome. Journal of Medical Genetics, 38(12), 834–845. https://doi.org/10.1136/jmg.38.12.834.CrossRefPubMedPubMedCentral

Luk, H. M., & Lo, I. F. (2016). Angelman syndrome in Hong Kong Chinese: A 20 years' experience. European Journal of Medical Genetics, 59(6–7), 315–319. https://doi.org/10.1016/j.ejmg.2016.05.003.CrossRefPubMed

Mertz, L. G., Christensen, R., Vogel, I., Hertz, J. M., Nielsen, K. B., Gronskov, K., & Ostergaard, J. R. (2013). Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis. American Journal of Medical Genetics. Part A, 161A(9), 2197–2203. https://doi.org/10.1002/ajmg.a.36058.CrossRefPubMed

Mertz, L. G., Thaulov, P., Trillingsgaard, A., Christensen, R., Vogel, I., Hertz, J. M., & Ostergaard, J. R. (2014). Neurodevelopmental outcome in Angelman syndrome: Genotype-phenotype correlations. Research in Developmental Disabilities, 35(7), 1742–1747. https://doi.org/10.1016/j.ridd.2014.02.018.CrossRefPubMed

Micheletti, S., Palestra, F., Martelli, P., Accorsi, P., Galli, J., Giordano, L., et al. (2016). Neurodevelopmental profile in Angelman syndrome: More than low intelligence quotient. Italian Journal of Pediatrics, 42(1), 91. https://doi.org/10.1186/s13052-016-0301-4.CrossRefPubMedPubMedCentral

Oiglane-Shlik, E., Talvik, T., Zordania, R., Poder, H., Kahre, T., Raukas, E., et al. (2006). Prevalence of Angelman syndrome and Prader-Willi syndrome in Estonian children: Sister syndromes not equally represented. American Journal of Medical Genetics. Part A, 140(18), 1936–1943. https://doi.org/10.1002/ajmg.a.31423.CrossRefPubMed

Pearson, E., Wilde, L., Heald, M., Royston, R., & Oliver, C. (2019). Communication in Angelman syndrome: A scoping review. Developmental Medicine and Child Neurology, 61(11), 1266–1274. https://doi.org/10.1111/dmcn.14257.CrossRefPubMed

Peters, S. U., Beaudet, A. L., Madduri, N., & Bacino, C. A. (2004). Autism in Angelman syndrome: Implications for autism research. Clinical Genetics, 66(6), 530–536. https://doi.org/10.1111/j.1399-0004.2004.00362.x.CrossRefPubMed

Peters, S. U., Horowitz, L., Barbieri-Welge, R., Taylor, J. L., & Hundley, R. J. (2012). Longitudinal follow-up of autism spectrum features and sensory behaviors in Angelman syndrome by deletion class. Journal of Child Psychology and Psychiatry, 53(2), 152–159. https://doi.org/10.1111/j.1469-7610.2011.02455.x.CrossRefPubMed

Quinn, E. D., & Rowland, C. (2017). Exploring expressive communication skills in a cross-sectional sample of children and young adults with Angelman syndrome. American Journal of Speech-Language Pathology, 26(2), 369–382. https://doi.org/10.1044/2016_AJSLP-15-0075.CrossRefPubMed

Roche, L., Sigafoos, J., & Trembath, D. (2020). Augmentative and alternative communication intervention for people with Angelman syndrome: A systematic review. Current Developmental Disorders Reports, 7(1), 28–34.CrossRef

Rowland, C., & Fried-Oken, M. (2010). Communication matrix: A clinical and research assessment tool targeting children with severe communication disorders. Journal of Pediatric Rehabilitation Medicine, 3(4), 319–329. https://doi.org/10.3233/PRM-2010-0144.CrossRefPubMed

Rubio-Codina, M., & Grantham-McGregor, S. (2020). Predictive validity in middle childhood of short tests of early childhood development used in large scale studies compared to the Bayley-III, the family care indicators, height-for-age, and stunting: A longitudinal study in Bogota, Colombia. PLoS One, 15(4), e0231317.CrossRefPubMedPubMedCentral

Sadhwani, A., Sanjana, N. E., Willen, J. M., Calculator, S. N., Black, E. D., Bean, L. J., et al. (2018). Two Angelman families with unusually advanced neurodevelopment carry a start codon variant in the most highly expressed UBE3A isoform. American Journal of Medical Genetics Part A, 176(7), 1641–1647. https://doi.org/10.1002/ajmg.a.38831.CrossRefPubMedPubMedCentral

Sahoo, T., Peters, S. U., Madduri, N. S., Glaze, D. G., German, J. R., Bird, L. M., et al. (2006). Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: Genotype-phenotype correlations. Journal of Medical Genetics, 43(6), 512–516. https://doi.org/10.1136/jmg.2005.036913.CrossRefPubMed

SAS. (2017). SAS Enterprise Guide. Version 7.1. Cary, NC: SAS Institute Inc.

Shaaya, E. A., Grocott, O. R., Laing, O., & Thibert, R. L. (2016). Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital. Epilepsy & Behavior: E&B, 60, 138–141. https://doi.org/10.1016/j.yebeh.2016.04.030.CrossRef

Singer, J. D., & Willett, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. Oxford: Oxford University Press.CrossRef

Tan, W. H., Bacino, C. A., Skinner, S. A., Anselm, I., Barbieri‐Welge, R., Bauer‐Carlin, A., et al. (2011). Angelman syndrome: Mutations influence features in early childhood. American Journal of Medical Genetics Part A, 155(1), 81–90. https://doi.org/10.1002/ajmg.a.33775.CrossRef

Tan, W. H., Bird, L. M., Sadhwani, A., Barbieri-Welge, R. L., Skinner, S. A., Horowitz, L. T., et al. (2018). A randomized controlled trial of levodopa in patients with Angelman syndrome. American Journal of Medical Genetics. Part A, 176(5), 1099–1107. https://doi.org/10.1002/ajmg.a.38457.CrossRefPubMed

Varela, M. C., Kok, F., Otto, P. A., & Koiffmann, C. P. (2004). Phenotypic variability in Angelman syndrome: Comparison among different deletion classes and between deletion and UPD subjects. European Journal of Human Genetics, 12(12), 987. https://doi.org/10.1038/sj.ejhg.5201264.CrossRefPubMed

Weiss, L. G., Oakland, T., & Aylward, G. P. (Eds.). (2010). Bayley-III clinical use and interpretation. New York: Academic Press.

Wheeler, A. C., Okoniewski, K. C., Wylie, A., DeRamus, M., Hiruma, L. S., Toth, D., & Christian, R. B. (2019). Anxiety-associated and separation distress-associated behaviours in Angelman syndrome. Journal of Intellectual Disability Research, 63(10), 1234–1247. https://doi.org/10.1111/jir.12635.CrossRefPubMed

Williams, C. A., Beaudet, A. L., Clayton‐Smith, J., Knoll, J. H., Kyllerman, M., Laan, L. A., et al. (2006). Angelman syndrome 2005: Updated consensus for diagnostic criteria. American Journal of Medical Genetics Part A, 140(5), 413–418. https://doi.org/10.1002/ajmg.a.31074.CrossRefPubMed

Wink, L. K., Fitzpatrick, S., Shaffer, R., Melnyk, S., Begtrup, A. H., Fox, E., et al. (2015). The neurobehavioral and molecular phenotype of Angelman Syndrome. American Journal of Medical Genetics. Part A, 167A(11), 2623–2628. https://doi.org/10.1002/ajmg.a.37254.CrossRefPubMed

Yakoreva, M., Kahre, T., Zordania, R., Reinson, K., Teek, R., Tillmann, V., et al. (2019). A retrospective analysis of the prevalence of imprinting disorders in Estonia from 1998 to 2016. European Journal of Human Genetics, 27(11), 1649–1658. https://doi.org/10.1038/s41431-019-0446-x.CrossRefPubMedPubMedCentral

Titel: Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III
Auteurs: Anjali Sadhwani
Anne Wheeler
Angela Gwaltney
Sarika U. Peters
Rene L. Barbieri-Welge
Lucia T. Horowitz
Lisa M. Noll
Rachel J. Hundley
Lynne M. Bird
Wen-Hann Tan
Publicatiedatum: 30-01-2021
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 2/2023
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-020-04861-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2023

Promoting Positive Health Outcomes in an Urban Community-Based Physical Activity Intervention for Preschool Aged Children on the Autism Spectrum

Does the Neurotypical Human Have a ‘Theory of Mind’?

Changes in Attitudes and Knowledge after Trainings in a Clinical Care Pathway for Autism Spectrum Disorder

CGH Findings in Children with Complex and Essential Autistic Spectrum Disorder

Moderators of Age of Diagnosis in > 20,000 Females with Autism in Two Large US Studies

Newborn Auditory Brainstem Responses in Children with Developmental Disabilities